These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28892209)

  • 1. Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats.
    Slovak JE; Rivera SM; Hwang JK; Court MH; Villarino NF
    J Vet Intern Med; 2017 Nov; 31(6):1827-1832. PubMed ID: 28892209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of mycophenolic acid in healthy cats after twice-daily intravenous infusion of mycophenolate mofetil for three days.
    Slovak JE; Rivera-Velez SM; Hwang JK; Villarino NF
    Am J Vet Res; 2018 Oct; 79(10):1093-1099. PubMed ID: 30256137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of mycophenolic acid and its effect on CD4
    Slovak JE; Hwang JK; Rivera SM; Villarino NF
    J Vet Intern Med; 2019 Sep; 33(5):2020-2028. PubMed ID: 31423655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients.
    Armstrong VW; Tenderich G; Shipkova M; Parsa A; Koerfer R; Schröder H; Oellerich M
    Ther Drug Monit; 2005 Jun; 27(3):315-21. PubMed ID: 15905802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil.
    Jain A; Venkataramanan R; Kwong T; Mohanka R; Orloff M; Abt P; Kashyap R; Tsoulfas G; Mack C; Williamson M; Batzold P; Bozorgzadeh A
    Liver Transpl; 2007 Jun; 13(6):791-6. PubMed ID: 17538999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration.
    Bullingham R; Monroe S; Nicholls A; Hale M
    J Clin Pharmacol; 1996 Apr; 36(4):315-24. PubMed ID: 8728345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Study of Continuous Infusion of Mycophenolate Mofetil for Prophylaxis of Graft-versus-Host-Disease in Pediatric Patients.
    Windreich RM; Goyal RK; Joshi R; Kenkre TS; Howrie D; Venkataramanan R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):682-689. PubMed ID: 26740371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients.
    Barau C; Barrail-Tran A; Hemerziu B; Habes D; Taburet AM; Debray D; Furlan V
    Liver Transpl; 2011 Oct; 17(10):1152-8. PubMed ID: 21695772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients.
    Graff J; Scheuermann EH; Brandhorst G; Oellerich M; Gossmann J
    Ther Drug Monit; 2016 Jun; 38(3):388-92. PubMed ID: 26829599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.
    Pescovitz MD; Conti D; Dunn J; Gonwa T; Halloran P; Sollinger H; Tomlanovich S; Weinstein S; Inokuchi S; Kiberd B; Kittur D; Merion RM; Norman D; Shoker A; Wilburn R; Nicholls AJ; Arterburn S; Dumont E
    Clin Transplant; 2000 Jun; 14(3):179-88. PubMed ID: 10831074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
    Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients.
    van Hest RM; Doorduijn JK; de Winter BC; Cornelissen JJ; Vulto AG; Oellerich M; Löwenberg B; Mathot RA; Armstrong VW; van Gelder T
    Ther Drug Monit; 2007 Jun; 29(3):353-60. PubMed ID: 17529894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD
    Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.
    Li H; Mager DE; Bemer MJ; Salinger DH; Vicini P; Sandmaier BM; Nash R; McCune JS
    J Clin Pharmacol; 2012 Nov; 52(11):1654-64. PubMed ID: 22174435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.
    Kaczmarek I; Bigdeli AK; Vogeser M; Mueller T; Beiras-Fernandez A; Kaczmarek P; Schmoeckel M; Meiser B; Reichart B; Ueberfuhr P
    Ther Drug Monit; 2008 Aug; 30(4):419-27. PubMed ID: 18641552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
    Jirasiritham S; Sumethkul V; Mavichak V; Na-Bangchang K
    Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients.
    Kurata K; Yakushijin K; Okamura A; Yamamori M; Ichikawa H; Sakai R; Mizutani Y; Kakiuchi S; Miyata Y; Kitao A; Kawamoto S; Matsuoka H; Murayama T; Minami H
    Cancer Chemother Pharmacol; 2018 May; 81(5):839-846. PubMed ID: 29511796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.